A randomized double-blind placebo-controlled study of Qingfei Jianpi desensitization prescription in early intervention of seasonal allergic rhinitis
- Conditions
- allergic rhinitis
- Registration Number
- ITMCTR2200006028
- Lead Sponsor
- Beijing Tongren Hospital ,Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Patients who meet the diagnostic criteria of Western medicine and TCM syndrome differentiation criteria;
(2) At least 2 years in the same season, the onset season of each year is basically the same, and it is consistent with the pollination period of sensitized pollen;
(3) The age ranged from 18 to 65 years;
(4)Voluntarily participate in this experimental study and voluntarily terminate all treatments that may affect the evaluation of the tested drug;
(5)Sign informed consent
(1)Those who have taken steroids in recent 2 weeks and antihistamines or topical steroids in 1 week;
(2)Perennial allergic rhinitis, acute rhinitis, or severe asthma combined with severe nasal septum deviation and hypertrophic rhinitis;
(3)Patients with serious primary diseases and psychosis such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
(4)Allergic to the drug;
(5)A woman who is pregnant, lactating or preparing for pregnancy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom score;
- Secondary Outcome Measures
Name Time Method nasal resistance;TCM syndrome score;Nasal sound reflection;RQLQ score;